Internal validation of an artificial neural network for prostate biopsy outcome: Original article

International Journal of Urology

Volumn 17, Issue 1, 2010, Pages 62-68

  Stephan, Carsten ^a   Cammann, Henning ^a   Bender, Martin ^a   Miller, Kurt ^a   Lein, Michael ^a,b   Jung, Klaus ^a,b   Meyer, Hellmuth A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin Institute for Urologic Research   (Germany)

Author keywords

Artificial neural network; Multivariate models; Prostate cancer; Prostate specific antigen; Validation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 74049098329     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02417.x     Document Type: Article

References (22)

1. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 2008 8 : 268 278.
2. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998 279 : 1542 1547.
3. Chun FK, Graefen M, Briganti A et al. Initial biopsy outcome prediction - head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur. Urol. 2007 51 : 1236 1240.
4. Finne P, Finne R, Auvinen A et al. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 2000 56 : 418 422.
5. Kalra P, Togami J, Bansal BSG et al. A neurocomputational model for prostate carcinoma detection. Cancer 2003 98 : 1849 1854.
6. Kawakami S, Numao N, Okubo Y et al. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur. Urol. 2008 54 : 601 611.
7. Stephan C, Jung K, Cammann H et al. An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation. Int. J. Cancer 2002 99 : 466 473.
8. Kawamura K, Suzuki H, Kamiya N et al. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL. Int. J. Urol. 2008 15 : 598 603.
9. Chun FK, Karakiewicz PI, Briganti A et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int. 2007 99 : 794 800.
10. Schroder F, Kattan MW. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. Eur. Urol. 2008 54 : 274 290.
11. Stephan C, Cammann H, Meyer HA, Lein M, Jung K. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer. Cancer Lett. 2007 249 : 18 29.
12. Karakiewicz PI, Benayoun S, Kattan MW et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J. Urol. 2005 173 : 1930 1934.
13. Stephan C, Cammann H, Semjonow A et al. Multicenter evaluation of an artificial neural network to increase prostate cancer detection rate and reduce unnecessary biopsies. Clin. Chem. 2002 48 : 1279 1287.
14. Stephan C, Cammann H, Meyer HA et al. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics. BJU Int. 2008 102 : 799 805.
15. Utsumi T, Kawamura K, Suzuki H et al. External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets. Int. J. Urol. 2009 16 : 416 419.
16. Stephan C, Xu C, Finne P et al. Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations. Urology 2007 70 : 596 601.
17. Stephan C, Meyer HA, Cammann H, Lein M, Loening SA, Jung K. Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction - head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur. Urol. 2007; 51: 1236-43. Eur. Urol. 2007 51 : 1446 1447.
18. Stephan C, Klaas M, Muller C, Schnorr D, Loening SA, Jung K. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin. Chem. 2006 52 : 59 64.
19. Stephan C, Xu C, Brown DA et al. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network. Prostate 2006 66 : 651 659.
20. Kairisto V, Poola A. Software for illustrative presentation of basic clinical characteristics of laboratory tests - GraphROC for Windows. Scand. J. Clin. Lab. Invest. 1995 55 : 43 60.
21. Scaramuzzino DA, Schulte K, Mack BN, Soriano TF, Fritsche HA. Five-year stability study of free and total prostate-specific antigen concentrations in serum specimens collected and stored at -70 degrees C or less. Int. J. Biol. Markers 2007 22 : 206 213.
22. Stephan C, Xu C, Cammann H et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4480 men. World. J. Urol. 2007 25 : 95 103.